Table: Zeria Pharm -2017/18 group results

Zeria Pharmaceutical

11/05/2018 08:00

May 11 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           64.57           64.85          68.00        33.00    
               (-0.4 pct)      (+3.8 pct)     (+5.3 pct)    (+1.8 pct) 
  Operating        4.83            4.54           5.20         2.50    
               (+6.4 pct)      (-0.5 pct)     (+7.7 pct)    (+4.4 pct) 
  Recurring        5.09            4.44           5.20         2.50    
               (+14.7 pct)     (-0.3 pct)     (+2.2 pct)    (-1.4 pct) 
  Net
  Net              4.16            3.54           4.30         2.20    
               (+17.3 pct)     (+0.9 pct)     (+3.4 pct)    (+3.4 pct) 
  EPS           80.72 yen       66.73 yen      85.36 yen    43.67 yen  
  Ann Div       34.00 yen       32.00 yen      34.00 yen               
  -Q2 Div       17.00 yen       16.00 yen      17.00 yen               
  -Q4 Div       17.00 yen       16.00 yen      17.00 yen               
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T